Delivery Order SPE2DB20D3101-SPE2DB24FQXA2

Award Date 12/15/23
Potential Completion Date 12/18/23
Potential Value $1.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,561,201,996 units of Triamterene-HCTZ 75-50 mg tablets. The fixed-price, firm-fixed-price delivery order has a ceiling value of $2,804.29 and an ultimate completion date of June 12, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,131.47, is for the supply of Triamterene-HCTZ 37.5-25 mg tablets in 100-count bottles. The contract has a period of performance through December 15, 2023 and uses a Firm Fixed Price pricing type. This contract award is not designated as a set-aside and...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,999.62, is a delivery order for Triamterene-HCTZ 37.5-25 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as a primary vehicle for Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,783.26 firm fixed-price delivery order is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a pharmaceutical product. The award has an ultimate completion date of January 31, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $3,409.58 under a Firm Fixed Price contract type. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to provide 4,563,472,748 units of the pharmaceutical product TRIAMTERENE 50 MG CAPSULE 100S. This contract has an ultimate completion date of January 31, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $1,241.94 that was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Triamterene-HCTZ 37.5-25 mg tablets, a medication used for the treatment of hypertension. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Triamterene 50 mg capsules to the Defense Logistics Agency (DLA). The award, valued at $5,104.10, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,952.91, is for the delivery of Triamterene-HCTZ 37.5-25 mg tablets in 500-count bottles. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,299.60 firm fixed price delivery order is for the supply of Triamterene-HCTZ 37.5-25 mg tablets in 500-count packages. The contract has an ultimate completion date of September 20, 2024 and does not utilize any set-asides. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of triamterene-HCTZ 75-50 mg tablets. The contract, valued at $1,167.96, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FQXA2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,563,301,694 units of the pharmaceutical product Triamterene-HCTZ 37.5-25 mg tablets in 500-count bottles. The Firm Fixed Price delivery order, valued at $1,361.16, has a completion date of December 18, 2023. This award is not designated with a set-aside requirement.

Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, Cencora, Inc. maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 10:22 AM